Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.84 USD | -2.24% | -2.00% | +142.72% |
04-10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
03-18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+142.72% | 906M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.20% | 22.25B | |
-13.14% | 22.09B | |
-8.35% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Truist Securities Lowers Price Target on Arcutis Biotherapeutics to $40 From $45, Maintains Buy Rating